Search clinical trials for: CIK cells

Total 10325 results

Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)

Lung Cancer

China
Chang Gung Memorial Hospital

Recruiting

Neoantigen-expanded Autologous Immune Cell Therapy

Advanced Solid Tumor

Taiwan
Peter Bader

Active, not recruiting

CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT.

Myelodysplastic Syndromes | Acute Leukemia

Germany
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer

Liver Cancer

China
Xiaoyi Huang

Unknown

Study of DC-CTL Combined With CIK for Advanced Solid Tumor

Renal Cell Carcinoma | Nasopharyngeal Carcinoma | Colorectal Cancer | Lung Cancer

China
A.O. Ospedale Papa Giovanni XXIII

Recruiting

Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell Transplant (Haplo-CIK)

Relapsed Hematologic Malignancy

Italy
The First People's Hospital of Changzhou

Not yet recruiting

CIK in Treating Patients With Esophageal Cancer

Esophageal Squamous Cell Carcinoma
The First People's Hospital of Changzhou

Active, not recruiting

CIK in Treating Patients With Bladder Cancer

Urinary Bladder Neoplasms
Singapore General Hospital
National Medical Research Council (NMRC), Singapore

Completed

Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Acute Myeloid Leukemia | Myelodysplastic Syndrome, High Grade

Singapore
Singapore General Hospital
National Medical Research Council (NMRC), Singapore

Completed

Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies (alloCIK)

Acute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Non Hodgkin's Lymphoma | Hodgkin's Disease

Singapore
Dalian University

Unknown

Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody

Non-small Cell Lung Cancer
A.O. Ospedale Papa Giovanni XXIII
Regional Hospital of Bolzano; Azienda Ospedaliera San Gerardo di Monza

Completed

Cytokine Induced Killer (CIK) Cells In Leukemia Patients (CIK2)

Hematologic Malignancies

Italy
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

Ovarian Carcinoma
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Cholangiocarcinoma

China
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer

Cervical Cancer
Guangxi Medical University

Unknown

Study of DC-CIK to Treat Colorectal Cancer

Colorectal Cancer

China
Guangxi Medical University

Unknown

Study of DC-CIK to Treat NPC

Nasopharyngeal Carcinoma

China
Beijing GoBroad Hospital

Not yet recruiting

CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction

Acute Lymphoblastic Leukemia, in Relapse | B-cell Acute Lymphoblastic Leukemia | Refractory Acute Lymphoid Leukemia

China
Sun Yat-sen University

Completed

CIK Treatment for HCC Patient Underwent Radical Resection

Carcinoma, Hepatocellular

China
Affiliated Hospital of Jiangnan University
West China Hospital; Hunan Cancer Hospital; Shenzhen Second People's Hospital; Zhejiang... and other collaborators

Recruiting

IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites

Pleural Effusion, Malignant

China
Sun Yat-sen University

Completed

Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver Cancer (HCC-CIK)

Hepatocellular Carcinoma

China
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)

Breast Cancer

China
Affiliated Hospital to Academy of Military Medical...

Unknown

Clinical Study of DC Plus CIK for Patients With Relapse Acute Leukemia After Allo-HSCT

Acute Leukemia

China
Affiliated Hospital to Academy of Military Medical...

Unknown

DC Vaccine Combined With CIK Cells in Patients With Esophagus Cancer

Esophagus Cancer

China
Allife Medical Science and Technology Co., Ltd.
Beijing Hospital; The First People's Hospital of Yunnan Province/First People... and other collaborators

Unknown

A Study of PD1 Combined With Dc-cik in the Treatment of Solid Tumors (DC-CIK)

Solid Tumor
Affiliated Hospital to Academy of Military Medical...

Unknown

DC Vaccine Combined With CIK Cells in Patients With SCLC

Small- Cell Lung Cancer
Yanjuan Zhu

Unknown

Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer (CIKCC)

Colonic Neoplasms

China
The First People's Hospital of Changzhou

Completed

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases

Colorectal Cancer

China
Gangnam Severance Hospital

Unknown

The Safety and Efficacy Test of Immuncell-LC to Treat Refractory Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Korea, Republic of
Southwest Hospital, China

Unknown

A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Guangxi Medical University

Unknown

A Study of DC-CIK to Treat Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)

China
Singapore General Hospital

Completed

Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy

Chronic Myeloid Leukemia

Singapore
The First People's Hospital of Changzhou

Not yet recruiting

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin
Henan Cancer Hospital
Henan Provincial People's Hospital; Hebei Medical University Fourth Hospital; Tangshan People's Hospital and other collaborators

Terminated

Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma

Lung Adenocarcinoma

China
Sun Yat-sen University

Unknown

GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma

Stage IV Nasopharyngeal Carcinoma

China
University College, London

Unknown

Autologous Stem Cells in Achilles Tendinopathy (ASCAT)

Tendinopathy | Achilles Tendinitis | Achilles Degeneration | Achilles Tendinitis, Right Leg | Achilles Tendon Thickening | Achilles Tendinitis, Left Leg

United Kingdom
Royan Institute

Completed

Evaluate the Effect of Bone Marrow Derived Cd133+ Cells in Patient With Osteonecrosis of Femoral Head

Osteonecrosis

Iran, Islamic Republic of
TrichoScience Innovations, Inc.
PRA Health Sciences; Pharmalog Institut für klinische Forschung GmbH (PHARMALOG... and other collaborators

Completed

Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia

Androgenetic Alopecia

Georgia
Joseph C. Wu
California Institute for Regenerative Medicine (CIRM)

Recruiting

Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction (HECTOR)

Chronic Ischemic Left Ventricular Dysfunction

United States
Tianjin Medical University Cancer Institute and...

Unknown

Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma

China
ShiCang Yu

Recruiting

Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer

Colorectal Cancer

China
Italian Sarcoma Group
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna

Withdrawn

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment. (CAST)

Sarcoma

Italy
University of California, Irvine
University of California, San Diego

Withdrawn

Autologous Cell Therapy After Stroke

Stroke

United States
Second Military Medical University

Unknown

Immunotherapy Using Pluripotent Killer-Programmed Cell Death 1 (PIK-PD-1) Cells for the Treatment of Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma

China
Chuan An Biotechnology Co., Ltd.

Unknown

A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA

Hepatocellular Carcinoma
Beijing Doing Biomedical Co., Ltd.

Unknown

Safety and Efficacy of γδ T Cell Against Gastric Cancer

Gastric Cancer

China
Johann Wolfgang Goethe University Hospital

Completed

Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arterial Occlusive Disease (PAOD)

Arterial Occlusive Diseases

Germany
Laura Johnston
National Institutes of Health (NIH)

Completed

Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD

Graft Versus Host Disease | Allogeneic Hematopoietic Cell Transplant Recipient

United States
James Baumgartner, MD
CBR Systems, Inc.

Completed

Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss

Sensorineural Hearing Loss

United States
Losordo, Douglas, M.D.

Completed

Stem Cell Study for Patients With Heart Disease

Myocardial Ischemia | Chest Pain | Heart Disease | Angina | Coronary Arterial Disease (CAD)

United States

Search clinical trials for: CIK cells

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations